OBJECTIVE: Family studies have suggested that postpartum mood symptoms might have a partly genetic etiology. The authors used a genome-wide linkage analysis to search for chromosomal regions that harbor genetic variants conferring susceptibility for such symptoms. The authors then fine-mapped their best linkage regions, assessing single nucleotide polymorphisms (SNPs) for genetic association with postpartum symptoms. METHOD: Subjects were ascertained from two studies: the NIMH Genetics Initiative Bipolar Disorder project and the Genetics of Recurrent Early-Onset Depression. Subjects included women with a history of pregnancy, any mood disorder, and information about postpartum symptoms. In the linkage study, 1,210 women met criteria (23% with postpartum symptoms), and 417 microsatellite markers were analyzed in multipoint allele sharing analyses. For the association study, 759 women met criteria (25% with postpartum symptoms), and 16,916 SNPs in the regions of the best linkage peaks were assessed for association with postpartum symptoms. RESULTS: The maximum linkage peak for postpartum symptoms occurred on chromosome 1q21.3-q32.1, with a chromosome-wide significant likelihood ratio Z score (Z(LR)) of 2.93 (permutation p=0.02). This was a significant increase over the baseline Z(LR) of 0.32 observed at this locus among all women with a mood disorder (permutation p=0.004). Suggestive linkage was also found on 9p24.3-p22.3 (Z(LR)=2.91). In the fine-mapping study, the strongest implicated gene was HMCN1 (nominal p=0.00017), containing four estrogen receptor binding sites, although this was not region-wide significant. CONCLUSIONS: This is the first study to examine the genetic etiology of postpartum mood symptoms using genome-wide data. The results suggest that genetic variations on chromosomes 1q21.3-q32.1 and 9p24.3-p22.3 may increase susceptibility to postpartum mood symptoms.
OBJECTIVE: Family studies have suggested that postpartum mood symptoms might have a partly genetic etiology. The authors used a genome-wide linkage analysis to search for chromosomal regions that harbor genetic variants conferring susceptibility for such symptoms. The authors then fine-mapped their best linkage regions, assessing single nucleotide polymorphisms (SNPs) for genetic association with postpartum symptoms. METHOD: Subjects were ascertained from two studies: the NIMH Genetics Initiative Bipolar Disorder project and the Genetics of Recurrent Early-Onset Depression. Subjects included women with a history of pregnancy, any mood disorder, and information about postpartum symptoms. In the linkage study, 1,210 women met criteria (23% with postpartum symptoms), and 417 microsatellite markers were analyzed in multipoint allele sharing analyses. For the association study, 759 women met criteria (25% with postpartum symptoms), and 16,916 SNPs in the regions of the best linkage peaks were assessed for association with postpartum symptoms. RESULTS: The maximum linkage peak for postpartum symptoms occurred on chromosome 1q21.3-q32.1, with a chromosome-wide significant likelihood ratio Z score (Z(LR)) of 2.93 (permutation p=0.02). This was a significant increase over the baseline Z(LR) of 0.32 observed at this locus among all women with a mood disorder (permutation p=0.004). Suggestive linkage was also found on 9p24.3-p22.3 (Z(LR)=2.91). In the fine-mapping study, the strongest implicated gene was HMCN1 (nominal p=0.00017), containing four estrogen receptor binding sites, although this was not region-wide significant. CONCLUSIONS: This is the first study to examine the genetic etiology of postpartum mood symptoms using genome-wide data. The results suggest that genetic variations on chromosomes 1q21.3-q32.1 and 9p24.3-p22.3 may increase susceptibility to postpartum mood symptoms.
Authors: Augustine Kong; Daniel F Gudbjartsson; Jesus Sainz; Gudrun M Jonsdottir; Sigurjon A Gudjonsson; Bjorgvin Richardsson; Sigrun Sigurdardottir; John Barnard; Bjorn Hallbeck; Gisli Masson; Adam Shlien; Stefan T Palsson; Michael L Frigge; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Kari Stefansson Journal: Nat Genet Date: 2002-06-10 Impact factor: 38.330
Authors: Layla Kassem; Victor Lopez; Don Hedeker; Jo Steele; Peter Zandi; Francis J McMahon Journal: Am J Psychiatry Date: 2006-10 Impact factor: 18.112
Authors: J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich Journal: Arch Gen Psychiatry Date: 1994-11
Authors: E N Smith; C S Bloss; J A Badner; T Barrett; P L Belmonte; W Berrettini; W Byerley; W Coryell; D Craig; H J Edenberg; E Eskin; T Foroud; E Gershon; T A Greenwood; M Hipolito; D L Koller; W B Lawson; C Liu; F Lohoff; M G McInnis; F J McMahon; D B Mirel; S S Murray; C Nievergelt; J Nurnberger; E A Nwulia; J Paschall; J B Potash; J Rice; T G Schulze; W Scheftner; C Panganiban; N Zaitlen; P P Zandi; S Zöllner; N J Schork; J R Kelsoe Journal: Mol Psychiatry Date: 2009-06-02 Impact factor: 15.992
Authors: Douglas F Levinson; George S Zubenko; Raymond R Crowe; Raymond J DePaulo; William S Scheftner; Myrna M Weissman; Peter Holmans; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; Stephanie Sassoon; James A Knowles; Jo Thomas; Jennifer Chellis Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2003-05-15 Impact factor: 3.568
Authors: Peter Holmans; George S Zubenko; Raymond R Crowe; J Raymond DePaulo; William A Scheftner; Myrna M Weissman; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; James A Knowles; Madeleine Gladis; Jo Thomas; Jennifer Chellis; Erin Miller; Douglas F Levinson Journal: Am J Hum Genet Date: 2004-04-22 Impact factor: 11.025
Authors: Mary Kimmel; Edward Hess; Patricia S Roy; Jennifer Teitelbaum Palmer; Samantha Meltzer-Brody; Jennifer M Meuchel; Emily Bost-Baxter; Jennifer L Payne Journal: Arch Womens Ment Health Date: 2014-07-01 Impact factor: 3.633
Authors: Crystal T Clark; Dorothy K Y Sit; Kara Driscoll; Heather F Eng; Andrea L Confer; James F Luther; Stephen R Wisniewski; Katherine L Wisner Journal: Depress Anxiety Date: 2015-06-08 Impact factor: 6.505
Authors: Katherine L Wisner; Dorothy K Y Sit; Mary C McShea; David M Rizzo; Rebecca A Zoretich; Carolyn L Hughes; Heather F Eng; James F Luther; Stephen R Wisniewski; Michelle L Costantino; Andrea L Confer; Eydie L Moses-Kolko; Christopher S Famy; Barbara H Hanusa Journal: JAMA Psychiatry Date: 2013-05 Impact factor: 21.596
Authors: Emma Robertson Blackmore; Jan A Moynihan; David R Rubinow; Eva K Pressman; Michelle Gilchrist; Thomas G O'Connor Journal: Psychosom Med Date: 2011-09-23 Impact factor: 4.312